This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2omh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2omh.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2omh.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2omh| PDB=2omh | SCENE= }}
{{STRUCTURE_2omh| PDB=2omh | SCENE= }}
-
'''Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea'''
+
===Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea===
-
==Overview==
+
<!--
-
Insulin NPH (neutral protamine hagedorn) has for long been one of the most important therapeutic formulations for the treatment of diabetes. The protracted action profile of NPH formulations is gained from crystallizing insulin with zinc in the presence of the basic poly-arginine peptide protamine. In spite of its long history and successful use, the binding mode of the insulin-protamine complex is not known. In this study, three different systems were used to study protamine binding to insulin. In the first system, crystals of an insulin-protamine complex grown in the presence of urea and diffracting to 1.5A resolution were analyzed. In the second system, a shorter peptide consisting of 12 arginine residues was co-crystallized with insulin in order to reduce the flexibility and thereby improve the electron density of the peptide. Both systems yielded data to a significantly higher resolution than obtained previously. In addition, a third system was analyzed where crystals of insulin and protamine were grown in the absence of urea, with conditions closely resembling the pharmaceutical formulation. Data from these NPH microcrystals could for the first time be collected to 2.2A resolution at a micro focused X-ray beamline. Analysis of all three crystal forms reveal potential protamine density located close to the solvent channel leading to the centrally located zinc atoms in the insulin hexamer and support that protamine binds to insulin in a not well defined conformation.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17339105}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17339105 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17339105}}
==About this Structure==
==About this Structure==
Line 25: Line 29:
[[Category: Schluckebier, G.]]
[[Category: Schluckebier, G.]]
[[Category: Insulin nph-like crystal]]
[[Category: Insulin nph-like crystal]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 11:12:51 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 10:56:23 2008''

Revision as of 07:56, 29 July 2008

Image:2omh.png

Template:STRUCTURE 2omh

Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea

Template:ABSTRACT PUBMED 17339105

About this Structure

2OMH is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural characterization of insulin NPH formulations., Norrman M, Hubalek F, Schluckebier G, Eur J Pharm Sci. 2007 Apr;30(5):414-23. Epub 2007 Jan 20. PMID:17339105

Page seeded by OCA on Tue Jul 29 10:56:23 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2omh"
Personal tools